Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction.

Penglei Jiang1,2,3, Zhaoru Zhang1,2,3, Yongxian Hu2,3,4

  • 1Center of Stem Cell and Regenerative Medicine, and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.

Leukemia
|August 12, 2022
PubMed
Summary

CAR-T cell exhaustion limits cancer therapy. This study reveals epigenetic regulators BATF and IRF4 drive exhaustion, and their knockdown improves CAR-T cell persistence and killing ability for better cancer treatment.